Trials / Conditions / Relapsed/Refractory Acute Lymphoblastic Leukemia
Relapsed/Refractory Acute Lymphoblastic Leukemia
3 registered clinical trials studyying Relapsed/Refractory Acute Lymphoblastic Leukemia — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | CD19 Chimeric Antigen Receptor (CAR) T Cells in Adults With Relapsed/Refractory CD19 Positive Acute Lymphoblas NCT07361029 | King Faisal Specialist Hospital & Research Center | Phase 1 |
| Unknown | Registry of Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia NCT05832125 | Versailles Hospital | — |
| Completed | An Study of Patients With Ph- Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the U NCT02783651 | Amgen | — |